The severe decline for shares of Express Scripts this month is a buying opportunity, according to Citi, which upgraded the company.
The St. Louis company's stock price closed at $50.05 on Wednesday and has plunged more than 20 percent since Express Scripts leaders said earlier on Nov. 6 that Wall Street expectations for 2013 earnings were "overly aggressive."
In contrast to that drop, Citi analyst George Hill noted that the Standard & Poor's 500 index has fallen 4 percent, while shares of Express Scripts' biggest competitors have dropped only 2 percent. Hill said in a Thursday morning research note that most investor concerns are now factored into the company's stock price, which reached an attractive level "with a compelling risk/reward profile should the company deliver on recently lowered investor expectations."
Hill raised his rating on the stock to "buy" from "neutral."
Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.
Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Critical BenefitsPRO information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
- Exclusive discounts on ALM, BenefitsPRO magazine and BenefitsPRO.com events
- Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
Already have an account? Sign In
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
